If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:59-92-7
Source:India
Qualifications:USDMF/-/-/-/-
Name | Levodopa |
---|---|
Chinese name | 左旋多巴 |
Cas Number | 59-92-7 |
Source | India |
Qualifications | USDMF/-/-/-/- |
Levodopa (Levodopa) is one of the precursors for the synthesis of norepinephrine and dopamine in humans and animals. It is a classic and irreplaceable anti-tremor paralysis drug. It is a precursor of the neurotransmitter dopamine with a catechin light base, commonly used For the drug treatment of Parkinson's disease. Levodopa is converted into dopamine by the decarboxylation of dopa decarboxylase in the brain, thereby exerting the effect of dopamine replacement therapy. After more than 40 years of clinical verification, this product is the most effective drug and the gold standard for the treatment of Parkinson's, with good tolerance and fewer adverse reactions. The combination of levodopa and peripheral dopa decarboxylase inhibitors, such as benserazide and carbidopa, has been introduced as an alternative therapy for dopamine deficiency in patients with Parkinson's disease (PD) for half a century. Today, the Therapy remains one of the most effective oral treatments.
Hot Tags: levodopa api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lapatinib Ditosylate API, Ulipristal Acetate API, Lurasidone Hydrochloride API, Edoxaban API, Valganciclovir Hydrochloride API, Solinasine Succinate API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China